RIM
BIO icon

Rakuten Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Rakuten Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$149K Buy
+615
New +$185K ﹤0.01% 653
2024
Q3 		$153K Sell
460
-451
-50% -$143K ﹤0.01% 504
2024
Q2 		$248K Buy
911
+342
+60% +$99.5K ﹤0.01% 448
2024
Q1 		$197K Buy
569
+517
+994% +$170K ﹤0.01% 437
2023
Q4 		$16.9K Buy
+52
New +$16.3K ﹤0.01% 434

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rakuten Investment Management's BIO Position: Q1 2025 in Review

Rakuten Investment Management opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2025: 615 shares worth $149K. The stake represents ﹤0.01% of the portfolio and ranks #653 among its holdings. This is a return to the name: Rakuten Investment Management previously reported a position in BIO as recently as Q3 2024.

Rakuten Investment Management first reported a position in BIO in Q4 2023 and has held it in 5 quarters since. The position peaked at $248K in Q2 2024. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Rakuten Investment Management held 615 shares of Bio-Rad Laboratories Class A worth $149K as of Q1 2025.
  • Bio-Rad Laboratories Class A was a new Rakuten Investment Management position in Q1 2025.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Rakuten Investment Management's portfolio in Q1 2025, its #653 holding.
  • Rakuten Investment Management first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 5 quarters since.
  • Rakuten Investment Management's Bio-Rad Laboratories Class A position peaked at $248K in Q2 2024.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Rakuten Investment Management's 13F filing for Q1 2025, filed 15 May 2025.